Angiogenesis, the process of generating new blood vessels from an existing vasculature, is essential in normal developmental processes such as endochondral ossification and in numerous kinds of pathogenesis including tumor growth. A part from the action of angiogenic factor or antiangiogenic factor, it is still unknown at which stage of the angiogenic cascade these agents affect angiogenesis. Here, we describe methods for the use of connective tissue growth factor (CTGF/CCN2) and CCN2 neutralizing antibody in the currently used principal angiogenesis assays, including those in vitro ones for the proliferation, migration, adhesion, and tube formation of endothelial cells and in vivo assays such as those utilizing type I collagen implantation and the chick chorioallantoic membrane (CAM).
CITATION STYLE
Shimo, T., & Takigawa, M. (2017). Cell biological assays for measuring angiogenic activities of CCN proteins. In Methods in Molecular Biology (Vol. 1489, pp. 239–249). Humana Press Inc. https://doi.org/10.1007/978-1-4939-6430-7_22
Mendeley helps you to discover research relevant for your work.